Key patient safety concern removed in new FDA guidance for non-US trials

HIV Treat Bull - 2008 May-June;9(5/6):25

The Helsinki Declaration issued by the World Medical Association (1989) was established to guide ethical principles of safety in clinical research and it is therefore extremely worrying that the FDA have removed one of the key recommendations from their guidance on US-based research that is carried out in poor countries.

Opposed by several advocacy groups, regarding use in the US of data collected in foreign clinical trials not under an IND, the rule eliminated the long-standing requirement that such studies must be conducted in accordance with the Declaration of Helsinki, the premier international protection document.

Although not prominently discussed by FDA, one of the principal motivations for their change was a US trade objection to a feature of the Declaration that supports greater access to proven therapies at the conclusion of study in par 30 of the Declaration, which states:

“30. At the conclusion of the study, every patient entered into the study should be assured of access to the best proven prophylactic, diagnostic and therapeutic methods identified by the study.”

Link to new rule:

http://www.fda.gov/cber/rules/forclinstud.pdf

AVAC comments against the proposed changes

http://www.fda.gov/ohrms/dockets/dailys/04/sep04/091704/04N-0018-emc00018-01.pdf

2008-05-10
IB080905-20

©2008. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.